Evaluation of the Xpert MTB/XDR test for detection of isoniazid, fluoroquinolones, and second-line injectable drugs resistance to Mycobacterium tuberculosis—Anhui Province, China
The Xpert MTB/XDR has high sensitivity and specificity in drug-resistant tuberculosis patients, making it better suited to meet the needs of rapid, sensitive, and accurate detection for drug-resistant tuberculosis in resource-limited settings, and serving as a critical tool for achieving personalized treatment and TB control.
Authors
- Bin Zhao (ORCID: https://orcid.org/0000-0002-3530-2469)
- Xundi Bao (ORCID: https://orcid.org/0000-0001-6596-2081)
- Zhou Liu
- 崇匡 佐藤
- Xichao Ou (ORCID: https://orcid.org/0000-0002-3126-4450)
- Fangjin Bao
- Yanlin Zhao (ORCID: https://orcid.org/0000-0002-7890-4312)
- Ruida Xing (ORCID: https://orcid.org/0000-0001-9696-0214)
- Hui Xia
- Yue Li (ORCID: https://orcid.org/0000-0002-2949-0344)
- Dongfang Xu
- Ruiqing Zhang
Institutions
- Chinese Center For Disease Control and Prevention (CN)
- Anhui Provincial Center for Disease Control and Prevention (CN)
- National Institute for Communicable Disease Control and Prevention (CN)
- Beijing Center for Disease Prevention and Control (CN)
- Xi'an Chest Hospital (CN)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-09-12
- DOI
- https://doi.org/10.1371/journal.pone.0331264
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00